Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Perceptive eClinical and Kayentis have announced a strategic alliance to provide a fully integrated electronic Clinical Outcome Assessment (eCOA) and Interactive Response Technology (IRT) solution for global clinical trials.
read more
Thursday, September 10, 2015
Frontage, a full service contract research organization (CRO), has announced the appointment of Michael S. Willett, PharmD., RAC as President of its clinical business unit.
read more
Takeda Pharmaceutical and Seattle Genetics announced the Phase 3 ECHELON-1 clinical trial met its primary endpoint of a statistically significant improvement in modified PFS versus the control arm.
read more
Wednesday, March 20, 2019
Merck and NGM announced Merck has exercised its option to extend the research phase of the companies’ collaboration for an additional two-year period to March 2022.
read more
Thursday, November 05, 2020
Monaghan Medical Corporation (MMC) announced the opening of a new 65,000-square-foot facility that doubles the size of its previous headquarters building.
read more
Thursday, December 04, 2025
Benuvia Operations announced a strategic partnership with Cannovation Clinical Research Partners (CCRP), a global consultancy focused on cannabinoid and psychedelic therapeutic programs. Together, the organizations will create the industry's first ...
read more
The CCMI at the NUI Galway and Sexton Biotechnologies announced the approval by an EU Regulatory Authority of a protocol for the manufacture of allogeneic bone marrow MSCs to be given intravenously to high-risk corneal transplant recipients in the ...
read more
Wednesday, December 16, 2020
The Wasdell Group has announced that its Dundalk, Ireland facility has been certified to comply with the ISO 13485 standard for medical device manufacturing.
read more
Friday, December 20, 2013
Many Israeli pharmaceutical executives recently learned that the 505(b)(2) development process is an important tool that can significantly reduce costs and shorten the timeline for approval of new drugs, adding substantially to ROI.
read more
Wednesday, November 15, 2017
Agenus announced the receipt of a $4 million payment for the advancement of an undisclosed antibody under the license and research collaboration agreement with Merck.
read more
Clinilabs announced it has successfully completed an inspection by the FDA with no observations.
read more
Tergus Pharma, the leading topical Contract Development and Manufacturing Organization (CDMO), officially opened its new, 100,000 sq. ft. headquarters and commercial manufacturing facility with a ribbon-cutting ceremony on May 13, 2021.
read more
Monday, November 20, 2023
The recent merger of Symbio LLC and Dow Development Laboratories LLC with Proinnovera has given rise to Symbio Proinnovera, a dedicated dermatology-focused Contract Research Organization (CRO).
read more
CluePoints has launched the “CluePoints RBM and ICH E6 (R2) Starter Pack” to help SMEs achieve regulatory compliance through a “risk-based” approach.
read more
As drug manufacturing has globalized, ensuring that companies meet the FDA strict standards for producing safe, effective and high-quality medicines has become increasingly challenging.
read more